December 19, 2018 | Story Review

Guardian jumps to conclusions about an Alzheimer’s study that hasn’t even begun

The story’s headline states: “Virtual reality to help detect early risk of Alzheimer’s.” That is misleading. The researchers haven’t even recruited study participants yet, much less conducted the study or analyzed the results.

1 Star

Virtual reality to help detect early risk of Alzheimer’s

December 18, 2018 | Story Review

In story on experimental contraceptive gel, Reuters lets drug company control the narrative

This leaves both investors and lay audiences without enough information to evaluate how useful the new product will be, should it pass muster with the FDA.

3 Star

Evofem's birth control gel meets main study goal; shares rise

December 17, 2018 | Story Review

Using a single patient anecdote, ABC News hails DNA fertility test as ‘breakthrough’

Breakthrough? Based on the story of one patient?  We’re told the procedure hasn’t been done often. But how often, and what happened to the other women?

2 Star

How a breakthrough new fertility test is offering hope for families who have suffered miscarriages

December 13, 2018 | Story Review

Hard to find the journalism in this brief Reuters story on clinical trial results for psoriasis drug

The story mostly just rehashes a drug company news release.

2 Star

J&J says its psoriasis drug superior to Novartis' in study

December 10, 2018 | Story Review

A little more context would have boosted already-strong HealthDay story on drug for hot flashes

Did the study findings really earn a label of “game-changing?”

5 Star

Incontinence Drug May Cut Hot Flashes in Breast Cancer Survivors

December 6, 2018 | Story Review

Props to NPR for highlighting the need for balanced decision-making around statins

This story could have provided a bit more on costs, alternatives, and how this study was performed.

4 Star

Before Starting A Statin, Talk It Over With Your Doctor

November 30, 2018 | Story Review

Independent source injects caution into a HeathDay story on ‘nerve zap’ for back pain

It’s too bad those comments don’t appear until the end.

3 Star

Nerve Zap Might Ease Pain of Herniated Disk

November 29, 2018 | Story Review

Newsweek trumpets an ‘aggressive’ new cancer drug, but where’s the data?

This story relies on a news release, and it’s full of holes. Cost, harms, evidence, who might benefit — all go unaddressed.

1 Star


November 28, 2018 | Story Review

USA Today provides rosy speculation about an Alzheimer’s vaccine not yet tested in humans

The story played up wishful conjecture about slashing dementia cases in half.

3 Star

Researcher: Alzheimer's vaccine could cut dementia in half, human trials may be next

November 20, 2018 | Story Review

CNN delivers a balanced report on peanut allergy treatment

One girl’s story illustrates harms as well as benefits.

5 Star

Experimental treatment helps 2 out of 3 peanut allergy sufferers, study finds


Tips & Resources for Analyzing Health Care Claims

View More